Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04223856 |
|---|---|
| Brief Title: | Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer (EV-302) |
| First Submitted : | January 6, 2020 |
| First Submitted that Met QC Criteria : | January 8, 2020 |
| First Posted : | January 10, 2020 |
| Last Update Submitted that Met QC Criteria : | December 5, 2023 |
| Last Update Posted : | December 6, 2023 |